Infectious diseases are among the common leading causes of morbidity and mortality worldwide. Let’s take an example of the current scenario where the world is gripped by the novel…

Immunohistochemistry has helped to make surgical pathology the ‘gold standard’ for tumour diagnosis. Antibodies have been used extensively as molecular probes; however, there have been issues with their specificity,…

Biomarker Discovery A biomarker is a measurable indicator showing the presence or severity of a disease state. Using biomarkers to differentiate between healthy and diseased cells can enable…

28/09/2020 Collaboration to produce a rapid test for the COVID-19 coronavirus infection Aptamer Group, is pleased to announce that it has entered into a collaboration with Cytiva,…

Arron Tolley, CEO of Aptamer Group discusses the teams progress on COVID-19 tests: 17/06/2020 Scientists at York-based biotechnology company Aptamer Group are using their expertise to develop a COVID-19…

  Osteosarcoma (OS) is a highly aggressive pediatric cancer, characterized by frequent lung metastasis and pathologic bone destruction. Vascular endothelial growth factor A (VEGFA) that is highly expressed in OS…

The goal of personalized medicine is to precisely tailor treatment to the individual. To this end, the ability to measure drugs in the body rapidly and in real time…

The current wave of COVID-19 infections around the globe has resulted from a novel coronavirus employing its spike glycoprotein to bind with the protein binding sites of the host…

The RNA interference (RNAi) era, started by Fire and Mello in 1998 completely changed the vision of research involving cell control and therapeutic intervention. RNAi machinery starts from a…

Human immunodeficiency virus (HIV) is the primary cause of acquired immune deficiency syndrome (AIDS), which causes significant morbidity and mortality with a significant consequent decrease in the quality of…